Heterogeneous catalysts made with ion-exchange resins show over 99% yield of cyclic carbamates, suggesting a novel approach for CO2 utilization.
The coupling of CO 2 with aziridines offers an efficient, 100% atom‐economic route to synthesize high‐value cyclic carbamates. In this study, we present a heterogeneous catalytic system based on readily available iron(III) metallates supported on commercially available ion‐exchange resins (IERs) for the selective synthesis of 1,3‐oxazolidin‐2‐ones. Two polystyrene‐based IERs with different porosities, Amberlyst™ 26‐Cl (A26‐Cl, macroreticular) and Amberlite™ IRA‐400‐Cl (IRA400‐Cl, microporous) were evaluated. The results reveal a synergistic interaction between the iron metallate and the resin support, with the A26‐[FeCl 3 Br] catalyst outperforming the homogeneous counterpart under mild conditions (25 °C, CO 2 pressure = 0.8 MPa, 2 h), achieving up to >99% yield of the target oxazolidinone. A Design of Experiments (DoE) approach was applied to optimize reaction parameters, and the system's versatility was confirmed using aziridines with different substitution patterns. Overall, this work presents a scalable (up to 1 g) and cost‐effective method for CO 2 valorization into cyclic carbamates, highlighting experimentally the combined effect of polystyrene supports and ammonium ferrate active species.
No takes yet. Share an insight, caveat, or question.
Alberti et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: